Navigation Links
Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device
Date:11/20/2007

CHEADLE, England, BURLINGTON, Massachusetts and RAMBOUILLET, France, November 20 /PRNewswire/ -- Optasia Medical Ltd., a maker of model-based vision software for musculoskeletal radiography, and D3A Medical Systems SAS, a developer of High Resolution Digital Radiology for osteoarticular imaging, including qualitative and quantitative analysis of joint and bone tissues, announced today the integration of Optasia Medical's KneeAnalyzer(TM) analysis software into D3A's BMA(TM) High-Resolution Digital X-Ray imaging system. D3A's Skeletal Ultra Analysis technology enables rapid high resolution imaging of the knee for diagnosis and management of patients with osteoarthritis (OA) with a very low dose office-based system. The BMA design provides user-friendly patient positioning to enable rapid imaging for Joint Space Width (JSW) measurement utilizing a Posterior-anterior (PA) x-ray image of the knee with a proprietary positioning device for highly reproducible image acquisition.

The BMA image has a resolution of 8 lp/mm, which is 2-3 times better resolution than a standard x-ray image. The integrated high-resolution monitor allows the operator or physician to view the image immediately after acquisition for a real-time diagnosis. The KneeAnalyzer(TM) software is completely integrated into the BMA system, allowing instantaneous analysis of the resulting image. KneeAnalyzer(TM) utilizes Optasia's proprietary model-based vision technology to assess Minimum Joint Space Width (mJSW), Joint Space Profile, and Fractal Signature Analysis of the sub-chondral bone. Also supported is the integrated comparison between baseline and follow-up visits.

Time from acquisition of image to complete KneeAnalyzer analysis report is less than 2 minutes, empowering the physician to review objective, quantitative analysis data during the office visit. Reduced operator dependency provided by KneeAnalyzer(TM), combined with high resolution images delivered by BMA concur to an enhanced precision in the assessment of the osteoarthritis disease. Expected benefits include improved monitoring of the disease evolution and faster evaluation of therapeutic actions.

The release of the BMA High-Resolution Digital X-Ray unit with Optasia Medical's KneeAnalyzer software is a result of an on-going collaboration between D3A and Optasia Medical. The next release of the BMA system will include Optasia's HandAnalyzer software for the management of rheumatoid arthritis and psoriatic arthritis

About D3ATM Medical Systems

D3A Medical Systems designs, manufactures and markets the BMA unit, a highly specialized high-resolution X Ray imaging device suited for the qualitative and quantitative analysis of joints and bone tissues. BMA provides a unique tool for the measurement of bone microarchitecture destruction by Fractal Texture Analysis. Thanks to its characteristics, BMA is used for diagnosis and treatment monitoring in osteoporosis, rheumatoid arthritis and osteoarthritis.

About Optasia Medical

Optasia Medical makes software that facilitates the reading of x-rays for the management of patients with musculoskeletal disease. Optasia's software applications - KneeAnalyzer(TM) for osteoarthritis, HandAnalyzer(TM) for rheumatoid arthritis and SpineAnalyzer for osteoporosis - are all based on the Optasia(R) Platform which employs model-based vision technology to detect, measure, classify and compare 2-dimensional medical images. Optasia's software applications are used in clinical trials and by physicians to identify and monitor patients who will benefit from treatment.


'/>"/>
SOURCE Optasia Medical Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
2. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
3. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
4. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
5. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
6. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
7. Digital pioneer wins national physics prize
8. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
9. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
10. Imaging Diagnostic Systems Generates Cash From Building Sale
11. Imaging quantum entanglement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... JUNCTION, N.J. , Feb. 4, 2016 /PRNewswire/ ... care immunotherapy leader commercializing its flagship CytoSorb® blood ... cardiac surgery patients around the world, announced that ... will present at the Source Capital Group,s 2016 ... and update on the company.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/3/2016)...  Discovery Laboratories, Inc. (NASDAQ: DSCO ), ... surfactant therapies for respiratory diseases, today announced that ... award as a component of employment compensation for ... and Chief Executive Officer.  The award was approved ... 2016 and granted as an inducement material to ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading ... to the North American healthcare market. , Aerocom Healthcare, LLC will be based ... company will provide new pneumatic tube systems or expand existing systems within the ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):